Target intelligence / Profile preview

Microbial cell membrane and intracellular component

Molecular classification
Other (not a specific molecule, but a collection of structures and biomolecules)
01

Overview

Microbial cell membranes are lipid bilayer structures consisting primarily of phospholipids and proteins (bacterial membranes do not contain cholesterol)[1][4][7]. They serve as highly selective barriers, controlling the import and export of molecules, maintaining separation between the cell and its environment, and enabling energy production and signal transduction[3][9][10]. Intracellular components encompass all molecules inside the cell, such as ribosomes, DNA/nucleoid, enzymes, plasmids, and, in eukaryotes, membrane-bound organelles[3][4]. Structurally, the bacterial envelope also includes specialized layers such as peptidoglycan and, for Gram-negative bacteria, an outer membrane rich in lipopolysaccharide[4]. These systems are common targets for antibiotics and antimicrobial peptides, though the term is too broad to serve as a specific therapeutic target.\nThe entry "Microbial cell membranes and intracellular components" is not a standard drug target and should instead be divided into specific, well-defined molecular entities for structured annotation.

Other names
Bacterial cell envelopeplasma membrane (for membrane only)cytoplasmic membranecell membraneintracellular organelles (for eukaryotes)protoplasm
02

Mechanism of action

Disruption of membrane integrity (AMPs cause pore formation and lysis)\nInhibition of intracellular processes (antibiotics inhibiting translation, DNA replication, or enzymatic functions within cytoplasm)\nBlockade of transport or energy production functions

03

Biological functions

Protection of cell integritySelective permeability and transportEnergy production (sites of respiration or photosynthesis)Cell signaling (membrane proteins as receptors/channels)Structural support and compartmentalization
04

Disease associations

Infection (targeted by antibiotics and antimicrobial peptides)Other (due to non-specificity; role in host-pathogen interaction)
05

Safety considerations

Lack of selectivity (drugs disrupting microbial membranes may also harm human cell membranes)Resistance development (microbes alter membrane composition or block drug entry)Toxicity (membrane-targeting drugs may cause nephrotoxicity or neurotoxicity in humans)
06

Interacting drugs

Antimicrobial peptides (nisin, cecropins, defensins)

1 more in the full profile.

Beyond the preview

Go deeper on Microbial cell membrane and intracellular component.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial cell membrane and intracellular component.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call